Targeting cancer vulnerabilities with high-dose vitamin C

Area of Science:

• Oncology
• Biochemistry
• Pharmacology

Background:

• The use of vitamin C for cancer treatment has been controversial for decades.
• Recent research into vitamin C pharmacokinetics and preclinical studies has renewed interest in high-dose vitamin C therapy for cancer.

Purpose of the Study:

• To discuss how high-dose vitamin C can target key cancer cell vulnerabilities.
• To explore the potential of vitamin C in cancer treatment by examining its effects on redox imbalance, epigenetic reprogramming, and oxygen-sensing regulation.

Main Methods:

• Review of recent preclinical studies and pharmacokinetic data.
• Discussion of proposed mechanisms of action for pharmacological vitamin C in cancer cells.

Main Results:

• Pharmacological doses of vitamin C appear to target critical mechanisms essential for cancer cell survival and proliferation.
• Vitamin C may disrupt redox balance, influence epigenetic modifications, and affect oxygen-sensing pathways in cancer cells.

Conclusions:

• New discoveries suggest vitamin C has anticancer properties by targeting cancer cell vulnerabilities.
• Further validation through well-controlled clinical trials is necessary to confirm these findings and optimize vitamin C therapy for specific cancer types and patient groups.